Clinical Trial Update: Combination of Cryosurgery and NK Immunotherapy for Advanced Breast Cancer [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 clinical trial evaluating the combination of cryosurgery and NK cell immunotherapy for breast cancer (recurrent) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Cryosurgery
• NK cell immunotherapy

Snippet

Sponsor: Fuda Cancer Hospital, Guangzhou | Conditions: Breast Cancer Recurrent | Phase 1, Phase 2 | Status: COMPLETED